Please Wait.....
Report
Allergy Immunotherapy Market By Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy) , By Application (Allergy Rhinitis, Asthma, Food Allergy, Others) By Distribution Channel (Hospital Pharmacies, Retail, Online Pharmacies) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 216 Pages I Allied Market Research
The allergy immunotherapy market was valued at $1.8 billion in 2023, and is projected to reach $4.9 billion by 2033, growing at a CAGR of 10.4% from 2024 to 2033.
Allergy immunotherapy is a preventative treatment for allergies that aims to mitigate the severity of allergic reactions to specific allergens such as house dust mites, bee venom, and grass pollens. This therapy involves gradual increase in administration of doses of the allergen to which an individual is allergic, thus making the immune systems less sensitive to the allergen and reducing the symptoms of allergy. The therapy can lead to long-term relief and decreased dependence on allergy medications.
The growth of the global allergy immunotherapy market is majorly driven by alarming rise in the prevalence of allergic conditions such as allergic rhinitis, asthma, and food allergies coupled with increase in awareness about allergy immunotherapy among patients and healthcare providers. Based on a 2011 study published in the White Book on Allergy, the prevalence rate of allergic rhinitis from 1% to 18%, skin allergies from 2% to 10%, and asthma ranges from 1% to 20% in various populations. Moreover, increase in preference of patients for effective and long-term solutions to allergy management fosters the demand for allergy immunotherapy, which significantly contributes toward the growth of the market. Furthermore, increase in trend toward personalized medicine is driving the demand for tailored immunotherapy treatments that address individual patient needs and specific allergies, which fosters the market growth. However, high cost of the associated with allergy immunotherapy and increase in concerns about the side effects of the treatment act as the key deterrent factors of the market. On the contrary, increase in healthcare expenditure in emerging markets is facilitating the access to advanced treatments like allergy immunotherapy, which is expected to offer remunerative opportunities for the growth of the market during the forecast period. Moreover, advancements in immunotherapy techniques, such as the development of sublingual immunotherapy and improved formulations of subcutaneous immunotherapy, are making treatments more effective and accessible, which are expected to open new avenues for the market growth.
The global allergy immunotherapy market is segmented into type, application, distribution channel, and region. On the basis of type, the market is categorized into subcutaneous immunotherapy and sublingual immunotherapy. By application, it is segregated into allergy rhinitis, asthma, food allergy, and others. Depending on distribution channel, it is fragmented into hospital pharmacies, retail, and online pharmacies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the subcutaneous immunotherapy (SCIT) segment held the highest market share in 2023.
By application, the allergic rhinitis segment is expected to exhibit highest growth rate by 2033.
Depending on distribution channel,, the hospital pharmacies segment is anticipated to gain high prominence during the forecast period.
Region wise, North America is projected to dominate the allergy immunotherapy market in the coming years.
Competition Analysis
Competitive analysis and profiles of the major players in the global allergy immunotherapy market include Torii Pharmaceutical Co., Ltd., Biomay AG, ALK-Abello A/S, Allergy Therapeutics, Allovate, LLC, HAL Allergy Group, Jubliant Pharma, Leti Pharma, Merck KGaA, and Stallergenes Greer. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and garner a strong foothold in the global market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Reimbursement Scenario
Key Market Segments
By Type
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
By Application
- Allergy Rhinitis
- Asthma
- Food Allergy
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail
- Online Pharmacies
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- Torii Pharmaceutical Co., Ltd.
- Biomay AG
- ALK-Abello A/S
- Allergy Therapeutics
- Allovate, LLC
- HAL Allergy Group
- Jubliant Pharma
- Leti Pharma
- Merck KGaA
- Stallergenes Greer
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: UNDERGROUND MINING MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Supported
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Unsupported
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Caving
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: UNDERGROUND MINING MARKET, BY OPERATOR
5.1. Market Overview
5.1.1 Market Size and Forecast, By Operator
5.2. Contract Mining
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Operator Mining
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: UNDERGROUND MINING MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Coal Mining
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Metal Mining
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Mineral Mining
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Others
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: UNDERGROUND MINING MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Operator
7.2.4. Market Size and Forecast, By Application
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Underground Mining Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Operator
7.2.6.3. Market Size and Forecast, By Application
7.2.7. Canada Underground Mining Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Operator
7.2.7.3. Market Size and Forecast, By Application
7.2.8. Mexico Underground Mining Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Operator
7.2.8.3. Market Size and Forecast, By Application
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Operator
7.3.4. Market Size and Forecast, By Application
7.3.5. Market Size and Forecast, By Country
7.3.6. France Underground Mining Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Operator
7.3.6.3. Market Size and Forecast, By Application
7.3.7. Germany Underground Mining Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Operator
7.3.7.3. Market Size and Forecast, By Application
7.3.8. Italy Underground Mining Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Operator
7.3.8.3. Market Size and Forecast, By Application
7.3.9. UK Underground Mining Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Operator
7.3.9.3. Market Size and Forecast, By Application
7.3.10. Rest of Europe Underground Mining Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Operator
7.3.10.3. Market Size and Forecast, By Application
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Operator
7.4.4. Market Size and Forecast, By Application
7.4.5. Market Size and Forecast, By Country
7.4.6. China Underground Mining Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Operator
7.4.6.3. Market Size and Forecast, By Application
7.4.7. Japan Underground Mining Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Operator
7.4.7.3. Market Size and Forecast, By Application
7.4.8. India Underground Mining Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Operator
7.4.8.3. Market Size and Forecast, By Application
7.4.9. South Korea Underground Mining Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Operator
7.4.9.3. Market Size and Forecast, By Application
7.4.10. Rest of Asia-Pacific Underground Mining Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Operator
7.4.10.3. Market Size and Forecast, By Application
7.5. Latin America
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Operator
7.5.4. Market Size and Forecast, By Application
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Underground Mining Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Operator
7.5.6.3. Market Size and Forecast, By Application
7.5.7. Argentina Underground Mining Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Operator
7.5.7.3. Market Size and Forecast, By Application
7.5.8. Rest of Underground Mining Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Operator
7.5.8.3. Market Size and Forecast, By Application
7.6. Middle East And Africa
7.6.1. Key Market Trends and Opportunities
7.6.2. Market Size and Forecast, By Product
7.6.3. Market Size and Forecast, By Operator
7.6.4. Market Size and Forecast, By Application
7.6.5. Market Size and Forecast, By Country
7.6.6. South Africa Underground Mining Market
7.6.6.1. Market Size and Forecast, By Product
7.6.6.2. Market Size and Forecast, By Operator
7.6.6.3. Market Size and Forecast, By Application
7.6.7. UAE Underground Mining Market
7.6.7.1. Market Size and Forecast, By Product
7.6.7.2. Market Size and Forecast, By Operator
7.6.7.3. Market Size and Forecast, By Application
7.6.8. Saudi Arabia Underground Mining Market
7.6.8.1. Market Size and Forecast, By Product
7.6.8.2. Market Size and Forecast, By Operator
7.6.8.3. Market Size and Forecast, By Application
7.6.9. Rest of Middle East And Africa Underground Mining Market
7.6.9.1. Market Size and Forecast, By Product
7.6.9.2. Market Size and Forecast, By Operator
7.6.9.3. Market Size and Forecast, By Application
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. BHP
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Anglo American PLC.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Rio Tinto
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Vale SA
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Implats Platinum Limited
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. MMC Norilsk Nickel PJSC
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Amur Minerals Corporation
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Alcoa Corporation
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. The Redpath Group
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. GBF Underground Mining Company Limited
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 2. ALLERGY IMMUNOTHERAPY MARKET FOR SUBCUTANEOUS IMMUNOTHERAPY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ALLERGY IMMUNOTHERAPY MARKET FOR SUBLINGUAL IMMUNOTHERAPY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 5. ALLERGY IMMUNOTHERAPY MARKET FOR ALLERGY RHINITIS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. ALLERGY IMMUNOTHERAPY MARKET FOR ASTHMA, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. ALLERGY IMMUNOTHERAPY MARKET FOR FOOD ALLERGY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. ALLERGY IMMUNOTHERAPY MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 10. ALLERGY IMMUNOTHERAPY MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. ALLERGY IMMUNOTHERAPY MARKET FOR RETAIL, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. ALLERGY IMMUNOTHERAPY MARKET FOR ONLINE PHARMACIES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. ALLERGY IMMUNOTHERAPY MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 17. NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 18. U.S. ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 19. U.S. ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 20. U.S. ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 21. CANADA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 22. CANADA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 23. CANADA ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 24. MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 25. MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 26. MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 27. EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 28. EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 29. EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 30. EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 31. FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 32. FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 33. FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 34. GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 35. GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 36. GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 37. ITALY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 38. ITALY ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 39. ITALY ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 40. SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 41. SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 42. SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 43. UK ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 44. UK ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 45. UK ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 46. REST OF EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 47. REST OF EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 48. REST OF EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 49. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 50. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 51. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 52. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 53. CHINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 54. CHINA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 55. CHINA ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 56. JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 57. JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 58. JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 59. INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 60. INDIA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 61. INDIA ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 62. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 63. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 64. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 65. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 66. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 67. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 68. REST OF ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 69. REST OF ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 70. REST OF ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 71. LAMEA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 72. LAMEA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 73. LAMEA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 74. LAMEA ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 75. BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 76. BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 77. BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 78. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 79. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 80. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 81. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 82. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 83. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 84. REST OF LAMEA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 85. REST OF LAMEA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 86. REST OF LAMEA ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($BILLION)
TABLE 87. TORII PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
TABLE 88. TORII PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 89. TORII PHARMACEUTICAL CO., LTD.: OPERATING SEGMENTS
TABLE 90. TORII PHARMACEUTICAL CO., LTD.: PRODUCT PORTFOLIO
TABLE 91. TORII PHARMACEUTICAL CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92. BIOMAY AG: KEY EXECUTIVES
TABLE 93. BIOMAY AG: COMPANY SNAPSHOT
TABLE 94. BIOMAY AG: OPERATING SEGMENTS
TABLE 95. BIOMAY AG: PRODUCT PORTFOLIO
TABLE 96. BIOMAY AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 97. ALK-ABELLO A/S: KEY EXECUTIVES
TABLE 98. ALK-ABELLO A/S: COMPANY SNAPSHOT
TABLE 99. ALK-ABELLO A/S: OPERATING SEGMENTS
TABLE 100. ALK-ABELLO A/S: PRODUCT PORTFOLIO
TABLE 101. ALK-ABELLO A/S: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 102. ALLERGY THERAPEUTICS: KEY EXECUTIVES
TABLE 103. ALLERGY THERAPEUTICS: COMPANY SNAPSHOT
TABLE 104. ALLERGY THERAPEUTICS: OPERATING SEGMENTS
TABLE 105. ALLERGY THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 106. ALLERGY THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107. ALLOVATE, LLC: KEY EXECUTIVES
TABLE 108. ALLOVATE, LLC: COMPANY SNAPSHOT
TABLE 109. ALLOVATE, LLC: OPERATING SEGMENTS
TABLE 110. ALLOVATE, LLC: PRODUCT PORTFOLIO
TABLE 111. ALLOVATE, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112. HAL ALLERGY GROUP: KEY EXECUTIVES
TABLE 113. HAL ALLERGY GROUP: COMPANY SNAPSHOT
TABLE 114. HAL ALLERGY GROUP: OPERATING SEGMENTS
TABLE 115. HAL ALLERGY GROUP: PRODUCT PORTFOLIO
TABLE 116. HAL ALLERGY GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117. JUBLIANT PHARMA: KEY EXECUTIVES
TABLE 118. JUBLIANT PHARMA: COMPANY SNAPSHOT
TABLE 119. JUBLIANT PHARMA: OPERATING SEGMENTS
TABLE 120. JUBLIANT PHARMA: PRODUCT PORTFOLIO
TABLE 121. JUBLIANT PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 122. LETI PHARMA: KEY EXECUTIVES
TABLE 123. LETI PHARMA: COMPANY SNAPSHOT
TABLE 124. LETI PHARMA: OPERATING SEGMENTS
TABLE 125. LETI PHARMA: PRODUCT PORTFOLIO
TABLE 126. LETI PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127. MERCK KGAA: KEY EXECUTIVES
TABLE 128. MERCK KGAA: COMPANY SNAPSHOT
TABLE 129. MERCK KGAA: OPERATING SEGMENTS
TABLE 130. MERCK KGAA: PRODUCT PORTFOLIO
TABLE 131. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132. STALLERGENES GREER: KEY EXECUTIVES
TABLE 133. STALLERGENES GREER: COMPANY SNAPSHOT
TABLE 134. STALLERGENES GREER: OPERATING SEGMENTS
TABLE 135. STALLERGENES GREER: PRODUCT PORTFOLIO
TABLE 136. STALLERGENES GREER: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ALLERGY IMMUNOTHERAPY MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ALLERGY IMMUNOTHERAPY MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALALLERGY IMMUNOTHERAPY MARKET
FIGURE 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SEGMENTATION, BY TYPE
FIGURE 11. ALLERGY IMMUNOTHERAPY MARKET FOR SUBCUTANEOUS IMMUNOTHERAPY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ALLERGY IMMUNOTHERAPY MARKET FOR SUBLINGUAL IMMUNOTHERAPY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SEGMENTATION, BY APPLICATION
FIGURE 14. ALLERGY IMMUNOTHERAPY MARKET FOR ALLERGY RHINITIS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. ALLERGY IMMUNOTHERAPY MARKET FOR ASTHMA, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. ALLERGY IMMUNOTHERAPY MARKET FOR FOOD ALLERGY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. ALLERGY IMMUNOTHERAPY MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SEGMENTATION, BY DISTRIBUTION CHANNEL
FIGURE 19. ALLERGY IMMUNOTHERAPY MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. ALLERGY IMMUNOTHERAPY MARKET FOR RETAIL, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. ALLERGY IMMUNOTHERAPY MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 26. COMPETITIVE DASHBOARD
FIGURE 27. COMPETITIVE HEATMAP: ALLERGY IMMUNOTHERAPY MARKET
FIGURE 28. TOP PLAYER POSITIONING, 2023
FIGURE 29. TORII PHARMACEUTICAL CO., LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 30. TORII PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 31. TORII PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 32. BIOMAY AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 33. BIOMAY AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 34. BIOMAY AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 35. ALK-ABELLO A/S: NET SALES, 2021-2023 ($BILLION)
FIGURE 36. ALK-ABELLO A/S: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 37. ALK-ABELLO A/S: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 38. ALLERGY THERAPEUTICS: NET SALES, 2021-2023 ($BILLION)
FIGURE 39. ALLERGY THERAPEUTICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 40. ALLERGY THERAPEUTICS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 41. ALLOVATE, LLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 42. ALLOVATE, LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 43. ALLOVATE, LLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 44. HAL ALLERGY GROUP: NET SALES, 2021-2023 ($BILLION)
FIGURE 45. HAL ALLERGY GROUP: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 46. HAL ALLERGY GROUP: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 47. JUBLIANT PHARMA: NET SALES, 2021-2023 ($BILLION)
FIGURE 48. JUBLIANT PHARMA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 49. JUBLIANT PHARMA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 50. LETI PHARMA: NET SALES, 2021-2023 ($BILLION)
FIGURE 51. LETI PHARMA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 52. LETI PHARMA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 53. MERCK KGAA: NET SALES, 2021-2023 ($BILLION)
FIGURE 54. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 55. MERCK KGAA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 56. STALLERGENES GREER: NET SALES, 2021-2023 ($BILLION)
FIGURE 57. STALLERGENES GREER: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 58. STALLERGENES GREER: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security